NNP
CVET

Nachman Norwood & Parrott’s Covetrus, Inc. Common Stock CVET Stock Holding History

Nachman Norwood & Parrott’s Portfolio CVET Stock Details CVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-260
Closed -$6K – 1138
2020
Q3 		$6K Buy
+260
New +$5.61K ﹤0.01% 928

Other funds holding CVET

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SG
SCHF (GPE) Wilson, Wyoming $781M AUM 24.06% 1-Year Est. Return
FCM
Freshford Capital Management Rye Brook, New York $200M AUM 31.49% 1-Year Est. Return

Nachman Norwood & Parrott's CVET Position: Q4 2020 in Review

Nachman Norwood & Parrott sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2020, closing a stake of 260 shares — an estimated $6K sold.

Nachman Norwood & Parrott first reported a position in CVET in Q3 2020 and held it in 1 quarter. The position peaked at $6K in Q3 2020. 277 funds tracked by Wall St. Rank hold CVET as of Q4 2020.

  • Nachman Norwood & Parrott reported no remaining Covetrus, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Nachman Norwood & Parrott sold 260 Covetrus, Inc. Common Stock shares in Q4 2020, an estimated $6K.
  • Nachman Norwood & Parrott first reported a position in Covetrus, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
  • Nachman Norwood & Parrott's Covetrus, Inc. Common Stock position peaked at $6K in Q3 2020.
  • 277 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2020.

Based on Nachman Norwood & Parrott's 13F filing for Q4 2020, filed 19 Jan 2021.